Global Pharmaceutical CDMO Solution Supply, Demand and Key Producers, 2023-2029
The global Pharmaceutical CDMO Solution market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Pharmaceutical CDMO Solution demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pharmaceutical CDMO Solution, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical CDMO Solution that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pharmaceutical CDMO Solution total market, 2018-2029, (USD Million)
Global Pharmaceutical CDMO Solution total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Pharmaceutical CDMO Solution total market, key domestic companies and share, (USD Million)
Global Pharmaceutical CDMO Solution revenue by player and market share 2018-2023, (USD Million)
Global Pharmaceutical CDMO Solution total market by Type, CAGR, 2018-2029, (USD Million)
Global Pharmaceutical CDMO Solution total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Pharmaceutical CDMO Solution market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Recipharm AB, Lonza Group, Catalent, Patheon (Thermo Fisher Scientific), Siegfried AG, SGS Quay Pharmaceuticals, Curia, Societal CDMO and Aenova Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical CDMO Solution market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pharmaceutical CDMO Solution Market, By Region:
1. How big is the global Pharmaceutical CDMO Solution market?
2. What is the demand of the global Pharmaceutical CDMO Solution market?
3. What is the year over year growth of the global Pharmaceutical CDMO Solution market?
4. What is the total value of the global Pharmaceutical CDMO Solution market?
5. Who are the major players in the global Pharmaceutical CDMO Solution market?
6. What are the growth factors driving the market demand?
This report studies the global Pharmaceutical CDMO Solution demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pharmaceutical CDMO Solution, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical CDMO Solution that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pharmaceutical CDMO Solution total market, 2018-2029, (USD Million)
Global Pharmaceutical CDMO Solution total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Pharmaceutical CDMO Solution total market, key domestic companies and share, (USD Million)
Global Pharmaceutical CDMO Solution revenue by player and market share 2018-2023, (USD Million)
Global Pharmaceutical CDMO Solution total market by Type, CAGR, 2018-2029, (USD Million)
Global Pharmaceutical CDMO Solution total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Pharmaceutical CDMO Solution market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Recipharm AB, Lonza Group, Catalent, Patheon (Thermo Fisher Scientific), Siegfried AG, SGS Quay Pharmaceuticals, Curia, Societal CDMO and Aenova Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical CDMO Solution market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pharmaceutical CDMO Solution Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Active Pharmaceutical Ingredient (API) Manufacturing
- Finished Dosage Formulation (FDF) Development and Manufacturing
- Secondary Packaging
- Others
- Innovative Medicine
- Patented Drug
- Patent Expired Drug
- Others
- Recipharm AB
- Lonza Group
- Catalent
- Patheon (Thermo Fisher Scientific)
- Siegfried AG
- SGS Quay Pharmaceuticals
- Curia
- Societal CDMO
- Aenova Group
- Eurofins CDMO
- Piramal Group
- WuXi AppTec Group
- Fareva
- Strides Pharma Science
- Famar Health Care Service
1. How big is the global Pharmaceutical CDMO Solution market?
2. What is the demand of the global Pharmaceutical CDMO Solution market?
3. What is the year over year growth of the global Pharmaceutical CDMO Solution market?
4. What is the total value of the global Pharmaceutical CDMO Solution market?
5. Who are the major players in the global Pharmaceutical CDMO Solution market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Pharmaceutical CDMO Solution Introduction
1.2 World Pharmaceutical CDMO Solution Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Pharmaceutical CDMO Solution Total Market by Region (by Headquarter Location)
1.3.1 World Pharmaceutical CDMO Solution Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Pharmaceutical CDMO Solution Market Size (2018-2029)
1.3.3 China Pharmaceutical CDMO Solution Market Size (2018-2029)
1.3.4 Europe Pharmaceutical CDMO Solution Market Size (2018-2029)
1.3.5 Japan Pharmaceutical CDMO Solution Market Size (2018-2029)
1.3.6 South Korea Pharmaceutical CDMO Solution Market Size (2018-2029)
1.3.7 ASEAN Pharmaceutical CDMO Solution Market Size (2018-2029)
1.3.8 India Pharmaceutical CDMO Solution Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pharmaceutical CDMO Solution Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pharmaceutical CDMO Solution Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Pharmaceutical CDMO Solution Consumption Value (2018-2029)
2.2 World Pharmaceutical CDMO Solution Consumption Value by Region
2.2.1 World Pharmaceutical CDMO Solution Consumption Value by Region (2018-2023)
2.2.2 World Pharmaceutical CDMO Solution Consumption Value Forecast by Region (2024-2029)
2.3 United States Pharmaceutical CDMO Solution Consumption Value (2018-2029)
2.4 China Pharmaceutical CDMO Solution Consumption Value (2018-2029)
2.5 Europe Pharmaceutical CDMO Solution Consumption Value (2018-2029)
2.6 Japan Pharmaceutical CDMO Solution Consumption Value (2018-2029)
2.7 South Korea Pharmaceutical CDMO Solution Consumption Value (2018-2029)
2.8 ASEAN Pharmaceutical CDMO Solution Consumption Value (2018-2029)
2.9 India Pharmaceutical CDMO Solution Consumption Value (2018-2029)
3 WORLD PHARMACEUTICAL CDMO SOLUTION COMPANIES COMPETITIVE ANALYSIS
3.1 World Pharmaceutical CDMO Solution Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Pharmaceutical CDMO Solution Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Pharmaceutical CDMO Solution in 2022
3.2.3 Global Concentration Ratios (CR8) for Pharmaceutical CDMO Solution in 2022
3.3 Pharmaceutical CDMO Solution Company Evaluation Quadrant
3.4 Pharmaceutical CDMO Solution Market: Overall Company Footprint Analysis
3.4.1 Pharmaceutical CDMO Solution Market: Region Footprint
3.4.2 Pharmaceutical CDMO Solution Market: Company Product Type Footprint
3.4.3 Pharmaceutical CDMO Solution Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Pharmaceutical CDMO Solution Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Pharmaceutical CDMO Solution Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Pharmaceutical CDMO Solution Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Pharmaceutical CDMO Solution Consumption Value Comparison
4.2.1 United States VS China: Pharmaceutical CDMO Solution Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pharmaceutical CDMO Solution Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Pharmaceutical CDMO Solution Companies and Market Share, 2018-2023
4.3.1 United States Based Pharmaceutical CDMO Solution Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Pharmaceutical CDMO Solution Revenue, (2018-2023)
4.4 China Based Companies Pharmaceutical CDMO Solution Revenue and Market Share, 2018-2023
4.4.1 China Based Pharmaceutical CDMO Solution Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Pharmaceutical CDMO Solution Revenue, (2018-2023)
4.5 Rest of World Based Pharmaceutical CDMO Solution Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Pharmaceutical CDMO Solution Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Pharmaceutical CDMO Solution Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pharmaceutical CDMO Solution Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Active Pharmaceutical Ingredient (API) Manufacturing
5.2.2 Finished Dosage Formulation (FDF) Development and Manufacturing
5.2.3 Secondary Packaging
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Pharmaceutical CDMO Solution Market Size by Type (2018-2023)
5.3.2 World Pharmaceutical CDMO Solution Market Size by Type (2024-2029)
5.3.3 World Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pharmaceutical CDMO Solution Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Innovative Medicine
6.2.2 Patented Drug
6.2.3 Patent Expired Drug
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Pharmaceutical CDMO Solution Market Size by Application (2018-2023)
6.3.2 World Pharmaceutical CDMO Solution Market Size by Application (2024-2029)
6.3.3 World Pharmaceutical CDMO Solution Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Recipharm AB
7.1.1 Recipharm AB Details
7.1.2 Recipharm AB Major Business
7.1.3 Recipharm AB Pharmaceutical CDMO Solution Product and Services
7.1.4 Recipharm AB Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Recipharm AB Recent Developments/Updates
7.1.6 Recipharm AB Competitive Strengths & Weaknesses
7.2 Lonza Group
7.2.1 Lonza Group Details
7.2.2 Lonza Group Major Business
7.2.3 Lonza Group Pharmaceutical CDMO Solution Product and Services
7.2.4 Lonza Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Lonza Group Recent Developments/Updates
7.2.6 Lonza Group Competitive Strengths & Weaknesses
7.3 Catalent
7.3.1 Catalent Details
7.3.2 Catalent Major Business
7.3.3 Catalent Pharmaceutical CDMO Solution Product and Services
7.3.4 Catalent Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Catalent Recent Developments/Updates
7.3.6 Catalent Competitive Strengths & Weaknesses
7.4 Patheon (Thermo Fisher Scientific)
7.4.1 Patheon (Thermo Fisher Scientific) Details
7.4.2 Patheon (Thermo Fisher Scientific) Major Business
7.4.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product and Services
7.4.4 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Patheon (Thermo Fisher Scientific) Recent Developments/Updates
7.4.6 Patheon (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
7.5 Siegfried AG
7.5.1 Siegfried AG Details
7.5.2 Siegfried AG Major Business
7.5.3 Siegfried AG Pharmaceutical CDMO Solution Product and Services
7.5.4 Siegfried AG Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Siegfried AG Recent Developments/Updates
7.5.6 Siegfried AG Competitive Strengths & Weaknesses
7.6 SGS Quay Pharmaceuticals
7.6.1 SGS Quay Pharmaceuticals Details
7.6.2 SGS Quay Pharmaceuticals Major Business
7.6.3 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product and Services
7.6.4 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 SGS Quay Pharmaceuticals Recent Developments/Updates
7.6.6 SGS Quay Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Curia
7.7.1 Curia Details
7.7.2 Curia Major Business
7.7.3 Curia Pharmaceutical CDMO Solution Product and Services
7.7.4 Curia Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Curia Recent Developments/Updates
7.7.6 Curia Competitive Strengths & Weaknesses
7.8 Societal CDMO
7.8.1 Societal CDMO Details
7.8.2 Societal CDMO Major Business
7.8.3 Societal CDMO Pharmaceutical CDMO Solution Product and Services
7.8.4 Societal CDMO Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Societal CDMO Recent Developments/Updates
7.8.6 Societal CDMO Competitive Strengths & Weaknesses
7.9 Aenova Group
7.9.1 Aenova Group Details
7.9.2 Aenova Group Major Business
7.9.3 Aenova Group Pharmaceutical CDMO Solution Product and Services
7.9.4 Aenova Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Aenova Group Recent Developments/Updates
7.9.6 Aenova Group Competitive Strengths & Weaknesses
7.10 Eurofins CDMO
7.10.1 Eurofins CDMO Details
7.10.2 Eurofins CDMO Major Business
7.10.3 Eurofins CDMO Pharmaceutical CDMO Solution Product and Services
7.10.4 Eurofins CDMO Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Eurofins CDMO Recent Developments/Updates
7.10.6 Eurofins CDMO Competitive Strengths & Weaknesses
7.11 Piramal Group
7.11.1 Piramal Group Details
7.11.2 Piramal Group Major Business
7.11.3 Piramal Group Pharmaceutical CDMO Solution Product and Services
7.11.4 Piramal Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Piramal Group Recent Developments/Updates
7.11.6 Piramal Group Competitive Strengths & Weaknesses
7.12 WuXi AppTec Group
7.12.1 WuXi AppTec Group Details
7.12.2 WuXi AppTec Group Major Business
7.12.3 WuXi AppTec Group Pharmaceutical CDMO Solution Product and Services
7.12.4 WuXi AppTec Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 WuXi AppTec Group Recent Developments/Updates
7.12.6 WuXi AppTec Group Competitive Strengths & Weaknesses
7.13 Fareva
7.13.1 Fareva Details
7.13.2 Fareva Major Business
7.13.3 Fareva Pharmaceutical CDMO Solution Product and Services
7.13.4 Fareva Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Fareva Recent Developments/Updates
7.13.6 Fareva Competitive Strengths & Weaknesses
7.14 Strides Pharma Science
7.14.1 Strides Pharma Science Details
7.14.2 Strides Pharma Science Major Business
7.14.3 Strides Pharma Science Pharmaceutical CDMO Solution Product and Services
7.14.4 Strides Pharma Science Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Strides Pharma Science Recent Developments/Updates
7.14.6 Strides Pharma Science Competitive Strengths & Weaknesses
7.15 Famar Health Care Service
7.15.1 Famar Health Care Service Details
7.15.2 Famar Health Care Service Major Business
7.15.3 Famar Health Care Service Pharmaceutical CDMO Solution Product and Services
7.15.4 Famar Health Care Service Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Famar Health Care Service Recent Developments/Updates
7.15.6 Famar Health Care Service Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pharmaceutical CDMO Solution Industry Chain
8.2 Pharmaceutical CDMO Solution Upstream Analysis
8.3 Pharmaceutical CDMO Solution Midstream Analysis
8.4 Pharmaceutical CDMO Solution Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Pharmaceutical CDMO Solution Introduction
1.2 World Pharmaceutical CDMO Solution Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Pharmaceutical CDMO Solution Total Market by Region (by Headquarter Location)
1.3.1 World Pharmaceutical CDMO Solution Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Pharmaceutical CDMO Solution Market Size (2018-2029)
1.3.3 China Pharmaceutical CDMO Solution Market Size (2018-2029)
1.3.4 Europe Pharmaceutical CDMO Solution Market Size (2018-2029)
1.3.5 Japan Pharmaceutical CDMO Solution Market Size (2018-2029)
1.3.6 South Korea Pharmaceutical CDMO Solution Market Size (2018-2029)
1.3.7 ASEAN Pharmaceutical CDMO Solution Market Size (2018-2029)
1.3.8 India Pharmaceutical CDMO Solution Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pharmaceutical CDMO Solution Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pharmaceutical CDMO Solution Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Pharmaceutical CDMO Solution Consumption Value (2018-2029)
2.2 World Pharmaceutical CDMO Solution Consumption Value by Region
2.2.1 World Pharmaceutical CDMO Solution Consumption Value by Region (2018-2023)
2.2.2 World Pharmaceutical CDMO Solution Consumption Value Forecast by Region (2024-2029)
2.3 United States Pharmaceutical CDMO Solution Consumption Value (2018-2029)
2.4 China Pharmaceutical CDMO Solution Consumption Value (2018-2029)
2.5 Europe Pharmaceutical CDMO Solution Consumption Value (2018-2029)
2.6 Japan Pharmaceutical CDMO Solution Consumption Value (2018-2029)
2.7 South Korea Pharmaceutical CDMO Solution Consumption Value (2018-2029)
2.8 ASEAN Pharmaceutical CDMO Solution Consumption Value (2018-2029)
2.9 India Pharmaceutical CDMO Solution Consumption Value (2018-2029)
3 WORLD PHARMACEUTICAL CDMO SOLUTION COMPANIES COMPETITIVE ANALYSIS
3.1 World Pharmaceutical CDMO Solution Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Pharmaceutical CDMO Solution Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Pharmaceutical CDMO Solution in 2022
3.2.3 Global Concentration Ratios (CR8) for Pharmaceutical CDMO Solution in 2022
3.3 Pharmaceutical CDMO Solution Company Evaluation Quadrant
3.4 Pharmaceutical CDMO Solution Market: Overall Company Footprint Analysis
3.4.1 Pharmaceutical CDMO Solution Market: Region Footprint
3.4.2 Pharmaceutical CDMO Solution Market: Company Product Type Footprint
3.4.3 Pharmaceutical CDMO Solution Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Pharmaceutical CDMO Solution Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Pharmaceutical CDMO Solution Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Pharmaceutical CDMO Solution Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Pharmaceutical CDMO Solution Consumption Value Comparison
4.2.1 United States VS China: Pharmaceutical CDMO Solution Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pharmaceutical CDMO Solution Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Pharmaceutical CDMO Solution Companies and Market Share, 2018-2023
4.3.1 United States Based Pharmaceutical CDMO Solution Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Pharmaceutical CDMO Solution Revenue, (2018-2023)
4.4 China Based Companies Pharmaceutical CDMO Solution Revenue and Market Share, 2018-2023
4.4.1 China Based Pharmaceutical CDMO Solution Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Pharmaceutical CDMO Solution Revenue, (2018-2023)
4.5 Rest of World Based Pharmaceutical CDMO Solution Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Pharmaceutical CDMO Solution Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Pharmaceutical CDMO Solution Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pharmaceutical CDMO Solution Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Active Pharmaceutical Ingredient (API) Manufacturing
5.2.2 Finished Dosage Formulation (FDF) Development and Manufacturing
5.2.3 Secondary Packaging
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Pharmaceutical CDMO Solution Market Size by Type (2018-2023)
5.3.2 World Pharmaceutical CDMO Solution Market Size by Type (2024-2029)
5.3.3 World Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pharmaceutical CDMO Solution Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Innovative Medicine
6.2.2 Patented Drug
6.2.3 Patent Expired Drug
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Pharmaceutical CDMO Solution Market Size by Application (2018-2023)
6.3.2 World Pharmaceutical CDMO Solution Market Size by Application (2024-2029)
6.3.3 World Pharmaceutical CDMO Solution Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Recipharm AB
7.1.1 Recipharm AB Details
7.1.2 Recipharm AB Major Business
7.1.3 Recipharm AB Pharmaceutical CDMO Solution Product and Services
7.1.4 Recipharm AB Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Recipharm AB Recent Developments/Updates
7.1.6 Recipharm AB Competitive Strengths & Weaknesses
7.2 Lonza Group
7.2.1 Lonza Group Details
7.2.2 Lonza Group Major Business
7.2.3 Lonza Group Pharmaceutical CDMO Solution Product and Services
7.2.4 Lonza Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Lonza Group Recent Developments/Updates
7.2.6 Lonza Group Competitive Strengths & Weaknesses
7.3 Catalent
7.3.1 Catalent Details
7.3.2 Catalent Major Business
7.3.3 Catalent Pharmaceutical CDMO Solution Product and Services
7.3.4 Catalent Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Catalent Recent Developments/Updates
7.3.6 Catalent Competitive Strengths & Weaknesses
7.4 Patheon (Thermo Fisher Scientific)
7.4.1 Patheon (Thermo Fisher Scientific) Details
7.4.2 Patheon (Thermo Fisher Scientific) Major Business
7.4.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product and Services
7.4.4 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Patheon (Thermo Fisher Scientific) Recent Developments/Updates
7.4.6 Patheon (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
7.5 Siegfried AG
7.5.1 Siegfried AG Details
7.5.2 Siegfried AG Major Business
7.5.3 Siegfried AG Pharmaceutical CDMO Solution Product and Services
7.5.4 Siegfried AG Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Siegfried AG Recent Developments/Updates
7.5.6 Siegfried AG Competitive Strengths & Weaknesses
7.6 SGS Quay Pharmaceuticals
7.6.1 SGS Quay Pharmaceuticals Details
7.6.2 SGS Quay Pharmaceuticals Major Business
7.6.3 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product and Services
7.6.4 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 SGS Quay Pharmaceuticals Recent Developments/Updates
7.6.6 SGS Quay Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Curia
7.7.1 Curia Details
7.7.2 Curia Major Business
7.7.3 Curia Pharmaceutical CDMO Solution Product and Services
7.7.4 Curia Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Curia Recent Developments/Updates
7.7.6 Curia Competitive Strengths & Weaknesses
7.8 Societal CDMO
7.8.1 Societal CDMO Details
7.8.2 Societal CDMO Major Business
7.8.3 Societal CDMO Pharmaceutical CDMO Solution Product and Services
7.8.4 Societal CDMO Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Societal CDMO Recent Developments/Updates
7.8.6 Societal CDMO Competitive Strengths & Weaknesses
7.9 Aenova Group
7.9.1 Aenova Group Details
7.9.2 Aenova Group Major Business
7.9.3 Aenova Group Pharmaceutical CDMO Solution Product and Services
7.9.4 Aenova Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Aenova Group Recent Developments/Updates
7.9.6 Aenova Group Competitive Strengths & Weaknesses
7.10 Eurofins CDMO
7.10.1 Eurofins CDMO Details
7.10.2 Eurofins CDMO Major Business
7.10.3 Eurofins CDMO Pharmaceutical CDMO Solution Product and Services
7.10.4 Eurofins CDMO Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Eurofins CDMO Recent Developments/Updates
7.10.6 Eurofins CDMO Competitive Strengths & Weaknesses
7.11 Piramal Group
7.11.1 Piramal Group Details
7.11.2 Piramal Group Major Business
7.11.3 Piramal Group Pharmaceutical CDMO Solution Product and Services
7.11.4 Piramal Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Piramal Group Recent Developments/Updates
7.11.6 Piramal Group Competitive Strengths & Weaknesses
7.12 WuXi AppTec Group
7.12.1 WuXi AppTec Group Details
7.12.2 WuXi AppTec Group Major Business
7.12.3 WuXi AppTec Group Pharmaceutical CDMO Solution Product and Services
7.12.4 WuXi AppTec Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 WuXi AppTec Group Recent Developments/Updates
7.12.6 WuXi AppTec Group Competitive Strengths & Weaknesses
7.13 Fareva
7.13.1 Fareva Details
7.13.2 Fareva Major Business
7.13.3 Fareva Pharmaceutical CDMO Solution Product and Services
7.13.4 Fareva Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Fareva Recent Developments/Updates
7.13.6 Fareva Competitive Strengths & Weaknesses
7.14 Strides Pharma Science
7.14.1 Strides Pharma Science Details
7.14.2 Strides Pharma Science Major Business
7.14.3 Strides Pharma Science Pharmaceutical CDMO Solution Product and Services
7.14.4 Strides Pharma Science Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Strides Pharma Science Recent Developments/Updates
7.14.6 Strides Pharma Science Competitive Strengths & Weaknesses
7.15 Famar Health Care Service
7.15.1 Famar Health Care Service Details
7.15.2 Famar Health Care Service Major Business
7.15.3 Famar Health Care Service Pharmaceutical CDMO Solution Product and Services
7.15.4 Famar Health Care Service Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Famar Health Care Service Recent Developments/Updates
7.15.6 Famar Health Care Service Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pharmaceutical CDMO Solution Industry Chain
8.2 Pharmaceutical CDMO Solution Upstream Analysis
8.3 Pharmaceutical CDMO Solution Midstream Analysis
8.4 Pharmaceutical CDMO Solution Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Pharmaceutical CDMO Solution Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Pharmaceutical CDMO Solution Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Pharmaceutical CDMO Solution Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Pharmaceutical CDMO Solution Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Pharmaceutical CDMO Solution Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pharmaceutical CDMO Solution Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Pharmaceutical CDMO Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Pharmaceutical CDMO Solution Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Pharmaceutical CDMO Solution Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Pharmaceutical CDMO Solution Players in 2022
Table 12. World Pharmaceutical CDMO Solution Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Pharmaceutical CDMO Solution Company Evaluation Quadrant
Table 14. Head Office of Key Pharmaceutical CDMO Solution Player
Table 15. Pharmaceutical CDMO Solution Market: Company Product Type Footprint
Table 16. Pharmaceutical CDMO Solution Market: Company Product Application Footprint
Table 17. Pharmaceutical CDMO Solution Mergers & Acquisitions Activity
Table 18. United States VS China Pharmaceutical CDMO Solution Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Pharmaceutical CDMO Solution Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Pharmaceutical CDMO Solution Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pharmaceutical CDMO Solution Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Pharmaceutical CDMO Solution Revenue Market Share (2018-2023)
Table 23. China Based Pharmaceutical CDMO Solution Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pharmaceutical CDMO Solution Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Pharmaceutical CDMO Solution Revenue Market Share (2018-2023)
Table 26. Rest of World Based Pharmaceutical CDMO Solution Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Pharmaceutical CDMO Solution Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Pharmaceutical CDMO Solution Revenue Market Share (2018-2023)
Table 29. World Pharmaceutical CDMO Solution Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & (USD Million)
Table 31. World Pharmaceutical CDMO Solution Market Size by Type (2024-2029) & (USD Million)
Table 32. World Pharmaceutical CDMO Solution Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & (USD Million)
Table 34. World Pharmaceutical CDMO Solution Market Size by Application (2024-2029) & (USD Million)
Table 35. Recipharm AB Basic Information, Area Served and Competitors
Table 36. Recipharm AB Major Business
Table 37. Recipharm AB Pharmaceutical CDMO Solution Product and Services
Table 38. Recipharm AB Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Recipharm AB Recent Developments/Updates
Table 40. Recipharm AB Competitive Strengths & Weaknesses
Table 41. Lonza Group Basic Information, Area Served and Competitors
Table 42. Lonza Group Major Business
Table 43. Lonza Group Pharmaceutical CDMO Solution Product and Services
Table 44. Lonza Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Lonza Group Recent Developments/Updates
Table 46. Lonza Group Competitive Strengths & Weaknesses
Table 47. Catalent Basic Information, Area Served and Competitors
Table 48. Catalent Major Business
Table 49. Catalent Pharmaceutical CDMO Solution Product and Services
Table 50. Catalent Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Catalent Recent Developments/Updates
Table 52. Catalent Competitive Strengths & Weaknesses
Table 53. Patheon (Thermo Fisher Scientific) Basic Information, Area Served and Competitors
Table 54. Patheon (Thermo Fisher Scientific) Major Business
Table 55. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product and Services
Table 56. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Patheon (Thermo Fisher Scientific) Recent Developments/Updates
Table 58. Patheon (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
Table 59. Siegfried AG Basic Information, Area Served and Competitors
Table 60. Siegfried AG Major Business
Table 61. Siegfried AG Pharmaceutical CDMO Solution Product and Services
Table 62. Siegfried AG Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Siegfried AG Recent Developments/Updates
Table 64. Siegfried AG Competitive Strengths & Weaknesses
Table 65. SGS Quay Pharmaceuticals Basic Information, Area Served and Competitors
Table 66. SGS Quay Pharmaceuticals Major Business
Table 67. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product and Services
Table 68. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. SGS Quay Pharmaceuticals Recent Developments/Updates
Table 70. SGS Quay Pharmaceuticals Competitive Strengths & Weaknesses
Table 71. Curia Basic Information, Area Served and Competitors
Table 72. Curia Major Business
Table 73. Curia Pharmaceutical CDMO Solution Product and Services
Table 74. Curia Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Curia Recent Developments/Updates
Table 76. Curia Competitive Strengths & Weaknesses
Table 77. Societal CDMO Basic Information, Area Served and Competitors
Table 78. Societal CDMO Major Business
Table 79. Societal CDMO Pharmaceutical CDMO Solution Product and Services
Table 80. Societal CDMO Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Societal CDMO Recent Developments/Updates
Table 82. Societal CDMO Competitive Strengths & Weaknesses
Table 83. Aenova Group Basic Information, Area Served and Competitors
Table 84. Aenova Group Major Business
Table 85. Aenova Group Pharmaceutical CDMO Solution Product and Services
Table 86. Aenova Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Aenova Group Recent Developments/Updates
Table 88. Aenova Group Competitive Strengths & Weaknesses
Table 89. Eurofins CDMO Basic Information, Area Served and Competitors
Table 90. Eurofins CDMO Major Business
Table 91. Eurofins CDMO Pharmaceutical CDMO Solution Product and Services
Table 92. Eurofins CDMO Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Eurofins CDMO Recent Developments/Updates
Table 94. Eurofins CDMO Competitive Strengths & Weaknesses
Table 95. Piramal Group Basic Information, Area Served and Competitors
Table 96. Piramal Group Major Business
Table 97. Piramal Group Pharmaceutical CDMO Solution Product and Services
Table 98. Piramal Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Piramal Group Recent Developments/Updates
Table 100. Piramal Group Competitive Strengths & Weaknesses
Table 101. WuXi AppTec Group Basic Information, Area Served and Competitors
Table 102. WuXi AppTec Group Major Business
Table 103. WuXi AppTec Group Pharmaceutical CDMO Solution Product and Services
Table 104. WuXi AppTec Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. WuXi AppTec Group Recent Developments/Updates
Table 106. WuXi AppTec Group Competitive Strengths & Weaknesses
Table 107. Fareva Basic Information, Area Served and Competitors
Table 108. Fareva Major Business
Table 109. Fareva Pharmaceutical CDMO Solution Product and Services
Table 110. Fareva Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Fareva Recent Developments/Updates
Table 112. Fareva Competitive Strengths & Weaknesses
Table 113. Strides Pharma Science Basic Information, Area Served and Competitors
Table 114. Strides Pharma Science Major Business
Table 115. Strides Pharma Science Pharmaceutical CDMO Solution Product and Services
Table 116. Strides Pharma Science Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Strides Pharma Science Recent Developments/Updates
Table 118. Famar Health Care Service Basic Information, Area Served and Competitors
Table 119. Famar Health Care Service Major Business
Table 120. Famar Health Care Service Pharmaceutical CDMO Solution Product and Services
Table 121. Famar Health Care Service Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Pharmaceutical CDMO Solution Upstream (Raw Materials)
Table 123. Pharmaceutical CDMO Solution Typical Customers
Table 1. World Pharmaceutical CDMO Solution Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Pharmaceutical CDMO Solution Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Pharmaceutical CDMO Solution Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Pharmaceutical CDMO Solution Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Pharmaceutical CDMO Solution Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pharmaceutical CDMO Solution Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Pharmaceutical CDMO Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Pharmaceutical CDMO Solution Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Pharmaceutical CDMO Solution Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Pharmaceutical CDMO Solution Players in 2022
Table 12. World Pharmaceutical CDMO Solution Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Pharmaceutical CDMO Solution Company Evaluation Quadrant
Table 14. Head Office of Key Pharmaceutical CDMO Solution Player
Table 15. Pharmaceutical CDMO Solution Market: Company Product Type Footprint
Table 16. Pharmaceutical CDMO Solution Market: Company Product Application Footprint
Table 17. Pharmaceutical CDMO Solution Mergers & Acquisitions Activity
Table 18. United States VS China Pharmaceutical CDMO Solution Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Pharmaceutical CDMO Solution Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Pharmaceutical CDMO Solution Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pharmaceutical CDMO Solution Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Pharmaceutical CDMO Solution Revenue Market Share (2018-2023)
Table 23. China Based Pharmaceutical CDMO Solution Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pharmaceutical CDMO Solution Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Pharmaceutical CDMO Solution Revenue Market Share (2018-2023)
Table 26. Rest of World Based Pharmaceutical CDMO Solution Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Pharmaceutical CDMO Solution Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Pharmaceutical CDMO Solution Revenue Market Share (2018-2023)
Table 29. World Pharmaceutical CDMO Solution Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & (USD Million)
Table 31. World Pharmaceutical CDMO Solution Market Size by Type (2024-2029) & (USD Million)
Table 32. World Pharmaceutical CDMO Solution Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & (USD Million)
Table 34. World Pharmaceutical CDMO Solution Market Size by Application (2024-2029) & (USD Million)
Table 35. Recipharm AB Basic Information, Area Served and Competitors
Table 36. Recipharm AB Major Business
Table 37. Recipharm AB Pharmaceutical CDMO Solution Product and Services
Table 38. Recipharm AB Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Recipharm AB Recent Developments/Updates
Table 40. Recipharm AB Competitive Strengths & Weaknesses
Table 41. Lonza Group Basic Information, Area Served and Competitors
Table 42. Lonza Group Major Business
Table 43. Lonza Group Pharmaceutical CDMO Solution Product and Services
Table 44. Lonza Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Lonza Group Recent Developments/Updates
Table 46. Lonza Group Competitive Strengths & Weaknesses
Table 47. Catalent Basic Information, Area Served and Competitors
Table 48. Catalent Major Business
Table 49. Catalent Pharmaceutical CDMO Solution Product and Services
Table 50. Catalent Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Catalent Recent Developments/Updates
Table 52. Catalent Competitive Strengths & Weaknesses
Table 53. Patheon (Thermo Fisher Scientific) Basic Information, Area Served and Competitors
Table 54. Patheon (Thermo Fisher Scientific) Major Business
Table 55. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product and Services
Table 56. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Patheon (Thermo Fisher Scientific) Recent Developments/Updates
Table 58. Patheon (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
Table 59. Siegfried AG Basic Information, Area Served and Competitors
Table 60. Siegfried AG Major Business
Table 61. Siegfried AG Pharmaceutical CDMO Solution Product and Services
Table 62. Siegfried AG Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Siegfried AG Recent Developments/Updates
Table 64. Siegfried AG Competitive Strengths & Weaknesses
Table 65. SGS Quay Pharmaceuticals Basic Information, Area Served and Competitors
Table 66. SGS Quay Pharmaceuticals Major Business
Table 67. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product and Services
Table 68. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. SGS Quay Pharmaceuticals Recent Developments/Updates
Table 70. SGS Quay Pharmaceuticals Competitive Strengths & Weaknesses
Table 71. Curia Basic Information, Area Served and Competitors
Table 72. Curia Major Business
Table 73. Curia Pharmaceutical CDMO Solution Product and Services
Table 74. Curia Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Curia Recent Developments/Updates
Table 76. Curia Competitive Strengths & Weaknesses
Table 77. Societal CDMO Basic Information, Area Served and Competitors
Table 78. Societal CDMO Major Business
Table 79. Societal CDMO Pharmaceutical CDMO Solution Product and Services
Table 80. Societal CDMO Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Societal CDMO Recent Developments/Updates
Table 82. Societal CDMO Competitive Strengths & Weaknesses
Table 83. Aenova Group Basic Information, Area Served and Competitors
Table 84. Aenova Group Major Business
Table 85. Aenova Group Pharmaceutical CDMO Solution Product and Services
Table 86. Aenova Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Aenova Group Recent Developments/Updates
Table 88. Aenova Group Competitive Strengths & Weaknesses
Table 89. Eurofins CDMO Basic Information, Area Served and Competitors
Table 90. Eurofins CDMO Major Business
Table 91. Eurofins CDMO Pharmaceutical CDMO Solution Product and Services
Table 92. Eurofins CDMO Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Eurofins CDMO Recent Developments/Updates
Table 94. Eurofins CDMO Competitive Strengths & Weaknesses
Table 95. Piramal Group Basic Information, Area Served and Competitors
Table 96. Piramal Group Major Business
Table 97. Piramal Group Pharmaceutical CDMO Solution Product and Services
Table 98. Piramal Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Piramal Group Recent Developments/Updates
Table 100. Piramal Group Competitive Strengths & Weaknesses
Table 101. WuXi AppTec Group Basic Information, Area Served and Competitors
Table 102. WuXi AppTec Group Major Business
Table 103. WuXi AppTec Group Pharmaceutical CDMO Solution Product and Services
Table 104. WuXi AppTec Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. WuXi AppTec Group Recent Developments/Updates
Table 106. WuXi AppTec Group Competitive Strengths & Weaknesses
Table 107. Fareva Basic Information, Area Served and Competitors
Table 108. Fareva Major Business
Table 109. Fareva Pharmaceutical CDMO Solution Product and Services
Table 110. Fareva Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Fareva Recent Developments/Updates
Table 112. Fareva Competitive Strengths & Weaknesses
Table 113. Strides Pharma Science Basic Information, Area Served and Competitors
Table 114. Strides Pharma Science Major Business
Table 115. Strides Pharma Science Pharmaceutical CDMO Solution Product and Services
Table 116. Strides Pharma Science Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Strides Pharma Science Recent Developments/Updates
Table 118. Famar Health Care Service Basic Information, Area Served and Competitors
Table 119. Famar Health Care Service Major Business
Table 120. Famar Health Care Service Pharmaceutical CDMO Solution Product and Services
Table 121. Famar Health Care Service Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Pharmaceutical CDMO Solution Upstream (Raw Materials)
Table 123. Pharmaceutical CDMO Solution Typical Customers
LIST OF FIGURES
Figure 1. Pharmaceutical CDMO Solution Picture
Figure 2. World Pharmaceutical CDMO Solution Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pharmaceutical CDMO Solution Total Market Size (2018-2029) & (USD Million)
Figure 4. World Pharmaceutical CDMO Solution Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Pharmaceutical CDMO Solution Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Pharmaceutical CDMO Solution Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Pharmaceutical CDMO Solution Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Pharmaceutical CDMO Solution Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Pharmaceutical CDMO Solution Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Pharmaceutical CDMO Solution Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Pharmaceutical CDMO Solution Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Pharmaceutical CDMO Solution Revenue (2018-2029) & (USD Million)
Figure 13. Pharmaceutical CDMO Solution Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 16. World Pharmaceutical CDMO Solution Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 18. China Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 23. India Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Pharmaceutical CDMO Solution by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Pharmaceutical CDMO Solution Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Pharmaceutical CDMO Solution Markets in 2022
Figure 27. United States VS China: Pharmaceutical CDMO Solution Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pharmaceutical CDMO Solution Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Pharmaceutical CDMO Solution Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Pharmaceutical CDMO Solution Market Size Market Share by Type in 2022
Figure 31. Active Pharmaceutical Ingredient (API) Manufacturing
Figure 32. Finished Dosage Formulation (FDF) Development and Manufacturing
Figure 33. Secondary Packaging
Figure 34. Others
Figure 35. World Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2029)
Figure 36. World Pharmaceutical CDMO Solution Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Pharmaceutical CDMO Solution Market Size Market Share by Application in 2022
Figure 38. Innovative Medicine
Figure 39. Patented Drug
Figure 40. Patent Expired Drug
Figure 41. Others
Figure 42. Pharmaceutical CDMO Solution Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. Pharmaceutical CDMO Solution Picture
Figure 2. World Pharmaceutical CDMO Solution Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pharmaceutical CDMO Solution Total Market Size (2018-2029) & (USD Million)
Figure 4. World Pharmaceutical CDMO Solution Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Pharmaceutical CDMO Solution Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Pharmaceutical CDMO Solution Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Pharmaceutical CDMO Solution Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Pharmaceutical CDMO Solution Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Pharmaceutical CDMO Solution Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Pharmaceutical CDMO Solution Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Pharmaceutical CDMO Solution Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Pharmaceutical CDMO Solution Revenue (2018-2029) & (USD Million)
Figure 13. Pharmaceutical CDMO Solution Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 16. World Pharmaceutical CDMO Solution Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 18. China Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 23. India Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Pharmaceutical CDMO Solution by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Pharmaceutical CDMO Solution Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Pharmaceutical CDMO Solution Markets in 2022
Figure 27. United States VS China: Pharmaceutical CDMO Solution Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pharmaceutical CDMO Solution Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Pharmaceutical CDMO Solution Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Pharmaceutical CDMO Solution Market Size Market Share by Type in 2022
Figure 31. Active Pharmaceutical Ingredient (API) Manufacturing
Figure 32. Finished Dosage Formulation (FDF) Development and Manufacturing
Figure 33. Secondary Packaging
Figure 34. Others
Figure 35. World Pharmaceutical CDMO Solution Market Size Market Share by Type (2018-2029)
Figure 36. World Pharmaceutical CDMO Solution Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Pharmaceutical CDMO Solution Market Size Market Share by Application in 2022
Figure 38. Innovative Medicine
Figure 39. Patented Drug
Figure 40. Patent Expired Drug
Figure 41. Others
Figure 42. Pharmaceutical CDMO Solution Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
